Hdl Apomics
Hospitals & Physicians Clinics · New Jersey, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
560 Main St Ste 2E, Allenhurst, New Jers...Phone Number
(732) 531-0501Website
www.hdl-apomics.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Hdl Apomics
HDL Apomics is an early stage, privately held company engaged in the discovery of monoclonal antibodies (mAb) and currently developing the first of its kind diagnostic arrays for the clinical testing of diseases that alter high-density lipoprotein (HDL) heterogeneity and diversity. Our approach aims to advance surrogate proteome markers to monitor distinct particle subpopulations and measure changes in their dynamic state. Using an immunoassay-based proteomic analysis generates a rapid, high-definition "HDL Fingerprint" for molecular phenotyping of HDL-related diseases. Companion diagnostics for both, cardiovascular disease (CVD) and Alzheimer's disease (AD), as well as drug screening for major cardiac adverse events (MACE) represent the most immediate opportunities for our approach.?Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Hdl Apomics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Hdl Apomics had a recent Job posting/layoffs
Hdl Apomics, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Hdl Apomics
Product Launch: Get notified when Hdl Apomics launches new products
Check out if Hdl Apomics is spiking on competitors!
Check if Hdl Apomics has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Hdl Apomics recently announced quarterly report
Funding: Get notified immidiatlly once Hdl Apomics has new funding data
Recommended Actions
Find VP level buyers at Hdl Apomics
Find 3 more new buyers
Compare Similar Companies to Hdl Apomics
Compare insights from companies similar to Hdl Apomics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Hdl Apomics
<$5M
11-50
Private
-
2011
N/A
Hdl Apomics Tech Stack
A closer look at the technologies used by Hdl Apomics
See more technologies
Top Hospitals & Physicians Clinics Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Hdl Apomics
Sign Up For FreeTo access detailed company insights
HDL Apomics is an early stage, privately held company engaged in the discovery of monoclonal antibodies (mAb) and currently developing the first of its kind diagnostic arrays for the clinical testing of diseases that alter high-density lipoprotein (HDL) heterogeneity and diversity. Our approach aims to advance surrogate proteome markers to monitor... Read More
